E company news, Mingde Biological (002932) announced on the evening of January 4 that the company's 2021 pre-profit of 1.3 billion yuan - 1.5 billion yuan, an increase of 177.23% - 219.88% year-on-year. During the reporting period, the company's sales of new crown nucleic acid detection reagents increased significantly; the company's overseas new crown testing reagents foreign trade orders and related revenue increased significantly; the penetration rate in primary medical and grade hospitals gradually increased, and the related income increased steadily.
![Mr. Matilda| don't miss me all the time, after I leave, you are me!"[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)